[Daily Medi] Skin Aesthetic Academic Event 'Re2O·RUSKIN X' Draws Joint Attention

Skin Aesthetic Academic Event ‘Re2O·RUSKIN X’ Draws Joint Attention

The skin booster ‘Re2O’ and the AI skin diagnostic device ‘RUSKIN X’ drew strong interest at the academic conference, demonstrating both product competitiveness and the potential for market expansion.

According to the industry on the 30th, medical staff, including plastic surgery specialists, continued to visit the L&C Bio booth at the 2026 BoPilSil (Botox, Filler, Thread Lifting) Society, recently held at the Plant Room of Seoul St. Mary’s Hospital.

The BoPilSil Society is an academic event centered on specialists in plastic surgery and skin aesthetics, where the latest procedure trends and clinical experience are shared. Interest in skin boosters and regenerative medicine-based procedures is growing.

With a program focused on real-world clinical application cases and procedural know-how, it is regarded as an important venue for exchange where the effectiveness and differentiation of products can be verified.

The response to Re2O confirmed on site was enthusiastic. Medical staff evaluated the treatment effects and patient satisfaction as excellent, and also cited the high proportion of foreign patient inflow and repeat visits as major strengths.

In particular, it was emphasized that the rate of referrals from acquaintances is high even without separate advertising, thanks to patient satisfaction with the treatment results, and it was assessed as having a growth structure based on natural inflow.

Interest in expanding the product lineup was also notable. In addition to the existing Re2O, inquiries about ‘Re2O Fine’ increased significantly. Specific consultations followed regarding the differentiating points from Re2O, treatment methods, pricing, and supply conditions.

RUSKIN X, Lulu Lab’s AI-based skin diagnostic device, also drew attention. Beyond simple interest, consultations about actual adoption and requests for hospital visits continued, showing that on-site reactions were leading to concrete business opportunities.

The industry is paying attention to the possibility that the strategy of an ‘integrated diagnosis-treatment platform’ through the combination of Re2O and RUSKIN X could become an important future growth pillar.

The lecture session also received strong interest. Dr. Hong Seong-taek of Mary Plastic Surgery gave a presentation in the skin booster session on ECM booster and skin booster market trends, product strengths, clinical application cases, and procedural know-how, drawing a positive response.

In particular, overall understanding and interest in ECM boosters increased significantly, and after the lecture, sample requests and inquiries about new consultations rose, leading to a real expansion in demand.

An industry insider said, “Through this academic conference, we confirmed both the expansion of Re2O’s existing user base and the inflow of new customers, and Re2O Fine proved its potential as a next-generation growth product.”

The insider added, “As RUSKIN X also secured a response that could lead to actual adoption, the strategy of integrating products and devices into a unified platform will likely accelerate further in the future.”

Original article URL : https://www.dailymedi.com/news/news_view.php?wr_id=935120